Skip to main content
Louis Philipson, MD, Endocrinology, Chicago, IL

Louis H Philipson MD PhD FACP (He/Him)

Diabetes, Lipid Metabolism


James Tyree Professor of Medicine and Pediatrics, University of Chicago Medicine Past President Science and Medicine, American Diabetes Association

Join to View Full Profile
  • 5841 S. MARYLAND AVE.M/C 1027Chicago, IL 60637

  • Phone+1 773-702-6138

  • Fax+1 773-834-4633

Dr. Philipson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Louis Philipson is an endocrinologist based in Chicago, IL, with subspecialties in diabetes and lipid metabolism. He holds a PhD in Biochemistry from the University of Chicago and an AB in Biochemistry from Harvard University. His extensive education includes a fellowship and residency at the University of Chicago, where he has served as a professor since 1990 and is the Director of the Kovler Comprehensive Diabetes Center. Dr. Philipson is known for his work on diabetes mellitus, hypoglycemia, insulin resistance, and type 1 diabetes. He has published several articles on these topics in reputable journals and has contributed to clinical trials. His professional commendations include being named among America's Top Doctors and Chicago’s Top Doctors by Castle Connolly, as well as receiving certification for meaningful use of electronic health records.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1991
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1986 - 1988
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1986
  • University of Chicago
    University of ChicagoPhD, Biochemistry, 1978 - 1982
  • Harvard University
    Harvard UniversityAB, Biochemistry, Cum Laude, 1972 - 1976

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1989 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2013-2022
  • Chicago Magazine: Top Doctors Castle Connolly, 2012-2022
  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes  
    Anuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA
  • Characterization of Mice Expressing Ins1 Gene Promoter Driven CreERT Recombinase for Conditional Gene Deletion in Pancreatic Beta-cells  
    Tamarina NA, Roe MW, Philipson L, Islets, 1/1/2014
  • Distribution of Directional Change as a Signature of Complex Dynamics  
    Burov, S., Tabei, Ali S.M., Huynh, T., Murrell, M., Philipson, L.H., Rice, S.A., Gardel, M.L., Scherer, N.F., Dinner, A.R., Proc Natl Acad Sci U S A., 1/3/2013

Books/Book Chapters

Lectures

  • Can We Prevent Type 1 Diabetes 
    Cairo, Egypt - 1/1/2015
  • Insulin Gene Mutations 
    Jerusalem, Israel - 1/1/2015
  • Monogenic Genes in Type 2 Diabetes 
    Vancouver, Canada - 1/1/2015

Other

Authored Content

  • Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020

Press Mentions

  • Kovler Diabetes Center Raises over $35K for Diabetes Care and Research at Salon Kovler Event
    Kovler Diabetes Center Raises over $35K for Diabetes Care and Research at Salon Kovler EventApril 5th, 2023
  • Most Humans Vulnerable to Type 2 Diabetes as Insulin Hits Evolutionary Dead-End
    Most Humans Vulnerable to Type 2 Diabetes as Insulin Hits Evolutionary Dead-EndNovember 7th, 2020
  • Beta-Cell β1 Integrin Deficiency Affects in Utero Development of Islet Growth and Vascularization
    Beta-Cell β1 Integrin Deficiency Affects in Utero Development of Islet Growth and VascularizationFebruary 15th, 2020

Grant Support

  • Center for Identification and Study of Individuals with Atypical Diabetes MellitusUNIVERSITY OF CHICAGO2018–2029
  • Monogenic Diabetes: Next Generation Diagnosis, Treatment and ComplicationsUNIVERSITY OF CHICAGO2016–2024
  • K+ Channel Expression In Pancreatic Beta-CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2011
  • Diabetes Research And Training CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2007
  • Imaging Beta Cell Function With BiosensorsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2007

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: